Comparison of baseline and four month follow up further implied the increasing importance of anti-inflammatory mechanisms possibly driven by IL-10 (CL1 −0.542) or IL-RA (CL1 0.704). The gene discussed is IL10; the disease is rheumatoid arthritis.